Patients with the highest cardiovascular risk are the least compliant with their antihypertensive therapy (DESIR study);Les hypertendus les plus à risque sont les moins observants (étude DESIR)

Archives des Maladies du Coeur et des Vaisseaux

Volumn 99, Issue 7-8, 2006, Pages 736-741

  Aumont, M C ^a,b   Allaert, F A ^c,d   Garnier, L ^e  

^a BICHAT HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL DU BOCAGE   (France)

^d MCGILL UNIVERSITY   (Canada)

^e INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANAMNESIS; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOLOGIST; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FACTORIAL ANALYSIS; FEMALE; FRANCE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; OBESITY; PATIENT COMPLIANCE; QUESTIONNAIRE; CROSS-SECTIONAL STUDY; HEALTH SURVEY; MIDDLE AGED; RISK FACTOR; SEX DIFFERENCE; SMOKING; TREATMENT REFUSAL;

ANTIHYPERTENSIVE AGENTS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HEALTH SURVEYS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; SEX FACTORS; SMOKING; TREATMENT REFUSAL;

EID: 33846849205     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Leverge. R. Les traitements antihypertenseurs. Pharmacie clinique Paris. Masson 2002.
2. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The seventh report of the joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC VII). JAMA 2003;289:2534-73.
3. Miller NH, Hill M, Kottke T, Ockene IS. The multilevel compliance challenge: recommendations for a call to action. A statement of healthcare professionals. Circulation 1997;95:1085-90.
4. Allaert FA, Gardette J. Analysis of patients' psychological reactions when faced with initial diagnosis or worsening of HBP. Tenth scientific meeting. Am J Hypertens 2005;100.
5. Laurent S, Consoli S, Girerd X, et al. Normalisation tensionnelle ou pas : vers de nouveaux éclairages. Arch Mal Cœur Vaiss 2001;94 (suppl):47.
6. Rudd P. Clinicians and patients with hypertension: unsettled issues about compliance. Am Heart J 1995;130:572-9.
7. Weber MA. Strategies for improving blood pressure control. Am J Hypertens 1998;11:897-9.
8. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions. JAMA 2002;288:2868-79.
9. Neutel JM, Smith DHG. Improving patient compliance: a major goal in the management of hypertension. J Clin Hypertens 2003;5:127-32.
10. Burnier M, Santschi V, Favrat B, Brunner HR. Monitoring compliance in resistant hypertension: an important step in patient management. J Hypertens 2003;21:S37-42.
11. Schroeder K, Fahey T, Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Arch Intern Med 2004;164:722-32.
12. Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 2004;19:357-62.
13. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97.
14. Horwitz RI, Horwitz SM. Adherence to treatment and health outcomes. Arch Intern Med 1993;153:1863-8.
15. Ménard J, Chatellier G. Limiting factors in the control of BP: why is there a gap between theory and practice? J Hum Hypertens 1995;9:S19-23.
16. Wetzels GEC, Nelemans P, Schouten JS, Prins MH. Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review. J Hypertens 2004;22:1849-55.
17. Girerd X, Radauceanu A, Achard JM, et al. Evaluation de l'observance par l'interrogatoire au cours du suivi des hypertendus dans des consultations spécialisées. Arch Mal Cœur Vaiss 2001;94:839-42.
18. Concato J, Peduzzi P, Holford TR, Feinstein AR. Importance of events per independent variable in proportional hazards analysis. I. Background, goals and general strategy. J Clin Epidemiology 1995;48:1495-501.
19. Fodor GJ, Kotrec M, Bacskai K, et al. Is interview a reliable method to verify the compliance with antihypertensive therapy? An international central-european study. J Hypertens 2005;23:1261-6.
20. Chapman RH, Benner JS, Petrilla AA, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med 2005;165:1147-52.
21. Mallion JM, Dutrey-Dupagne C, Vaur L, et al. Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension. J Hypertens 1996;14:137-44.
22. Vaur L, Vaisse B, Genes N, Elkrik F, Legrand C, Poggi L. Use of electronic pill boxes to assess risk of poor treatment compliance. Results of a large-scale trial. Am J Hypertens 1999;12:374-80.
23. Andrejak M, Genes M, Vaur L, Poncelet P, Clerson P, Carre A. Electronic pill-boxes in the evaluation of antihypertensive treatment compliance: comparison of once daily versus twice daily regimen. Am J Hypertens 2000;13:184-90.
24. Mounier-Vehier C, Bernard C, Carre A, Lequeuche B, Hotton JM, Charpentier JC. Compliance and antihypertensive efficacy of amlodipine compared with nifedipine slow-release. Am J Hypertens 1998;11:478-86.
25. Waeber B. What has been learned from electronic monitoring of compliance with antihypertensive medications? J Hypertens 2004;22:1857-8.
26. Wang PS, Bohn RL, Knight E, Glynn RJ, Mogun H, Avorn J. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med 2002;17:504-11.
27. Kjellgren KI, Ahlner J, Säljö R. Taking antihypertensive medication - controlling or co-operating with patients? Int J Cardiol 1995;47:257-68.
28. Haynes RB. McDonald HP, Garg AX. Helping patients follow prescribed treatment. Clinical applications. JAMA 2002;288:2880-3.
29. Degli-Esposti E, Sturani A, Di Martino M, et al. Long-term persistence with antihypertensive drugs in new patients. J Hum Hypertens 2002;16:439-44.
30. Mourad JJ, Bockle J, Krivitzky A, Anssens C, Allaert FA. Les pathologies du conjoint sont associées à la qualité du contrôle tensionnel des hypertendus âgés. Étude senior/seniora. Arch Mal Cœur Vaiss 2005;98:11.